Search

Filters

Clear Filters
3:00 PM - 4:00 PM ET

2055 - Evaluation of Meningioma With 64Cu-DOTATATE PET: Initial Single-Institution Experience
Speaker: Elangovan, Vignesh, BS - Department of Radiation Oncology, The University of Pittsburgh, Pittsburgh, PA
3:00 PM - 4:00 PM ET

2056 - Impact of Complete GTV Inclusion within =110% Isodose on Local Control and Toxicity after Spine Reirradiation SBRT
Speaker: Elguindy, Ahmed, MD - James Cancer Hospital-Solove Research Institute, Columbus, OH
3:00 PM - 4:00 PM ET

2057 - Discrepancies In Pancreatic Cancer Genomic Landscape between the Cancer Genome Atlas and a Large Single-Institution Database
Speaker: Ellsworth, Susannah, MD - University of Pittsburgh Cancer Centers, Pittsburgh, PA
3:00 PM - 4:00 PM ET

2058 - Stereotactic Body Radiotherapy (SBRT) in Unresectable Hepatocellular Carcinoma (HCC)- Prospective Study
Speaker: Engineer, Reena, MD - Tata Memorial Centre, Mumbai, Please Select
3:00 PM - 4:00 PM ET

2059 - Hypofractionated FLASH Carbon Ion Radiotherapy Outperforms Standard Dose-Rate Treatment in Genetically Engineered Pancreatic Cancer Models: Impact of Adaptive Immune Responses
Speaker: Eskandarian, Saleh, MS, MPE - German Cancer Research Center (DKFZ), Heidelberg, Baden-Wurt
11:15 AM - 11:25 AM ET

206 - Safety of Maintenance Pembrolizumab (Pembro) and Concurrent Radiotherapy (RT) in Pediatric Participants with Classic Hodgkin Lymphoma (cHL) and Slow Early Response (SER) to Front-Line Chemotherapy (Chemo): Post Hoc Analysis of the KEYNOTE-667 Study
Speaker: Hoppe, Bradford, MD, FASTRO, MPH - Mayo Clinic Florida, Jacksonville, FL
3:00 PM - 4:00 PM ET

2060 - Efficacy of Chemoradiotherapy Combined with Camrelizumab in Patients with Oligometastatic Esophageal Squamous Cell Carcinoma Who Previously Received Definitive Treatment: Preliminary Results of a Phase II Trail
Speaker: Fan, ChengCheng, MD - Henan Cancer Hospital, Zhengzhou, HeNan
3:00 PM - 4:00 PM ET

2061 - Effect of Combined Deep Hyperthermia Therapy on Radiation Proctitis in Patients with Rectal Cancer Receiving Neoadjuvant Chemoradiotherapy: A Single-Center Case-Control Study
Speaker: Fan, Chunbo - chongqing uninersity cancer hospital, chongqing, chongqing
3:00 PM - 4:00 PM ET

2062 - Medium Dose of TPF Chemotherapy with Concurrent Radiotherapy and Immunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma:A Prospective, Single Arm, Phase II Study (FUTURE-2)
Speaker: Fan, Xingwen, MD, PhD - Fudan University Shanghai Cancer Center, Shanghai, Shanghai
3:00 PM - 4:00 PM ET

2063 - Medium Dose of TPF Chemotherapy with Concurrent Radiotherapy and Immunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Real-World Study
Speaker: Fan, Xingwen, MD, PhD - Fudan University Shanghai Cancer Center, Shanghai, Shanghai
3:00 PM - 4:00 PM ET

2064 - Upfront Intracranial Brachytherapy Using Cs-131 Followed by External Beam Radiation Therapy vs. Stupp Protocol: A Pilot Voxel-by-Voxel Biological Effective Dose Comparison Accounting for Tumor Repopulation in Glioblastoma Patients
Speaker: Ferreira, Clara, PhD - University of Minnesota, Minneapolis, MN
3:00 PM - 4:00 PM ET

2065 - Treatment Related Factors and Survival Determinants in Pleomorphic Xanthoastrocytoma
Speaker: Feyisa, Jilcha, MD, MPH - Dartmouth-Hitchcock Medical Center, Lebanon, NH